» Articles » PMID: 37005342

Willingness to Get HPV Vaccination Among Female University Students in Kuwait and Its Relation to Vaccine Conspiracy Beliefs

Overview
Date 2023 Apr 2
PMID 37005342
Authors
Affiliations
Soon will be listed here.
Abstract

A substantial burden of high-risk human papillomavirus (HPV) infections and HPV-related cancers can be mitigated by vaccination. The current study aimed to investigate the willingness of female students at the University of Kuwait to get HPV vaccination and its possible association with general vaccine conspiracy beliefs (VCBs). This cross-sectional survey study was conducted during September-November 2022 using a validated VCB scale as the survey instrument. The final sample comprised 611 respondents with a median age of 22 y and a majority of Arab ethnicity ( = 600, 98.2%). Only 360 respondents (56.9%) heard of HPV before participation and these students showed an above-average level of HPV knowledge (mean knowledge score of 12.7 ± 2.6 out of 16 as the maximum score), of whom only 33 self-reported HPV vaccine uptake (9.2%). The willingness to accept free-of-charge HPV vaccination was seen among 69.8% of the participants, with 20.1% who were hesitant and 10.1% who were resistant. The acceptance of HPV vaccination if payment is required was 23.1%. Reasons for HPV vaccine hesitancy/resistance included complacency to the HPV disease risks, lack of confidence in HPV vaccination, and inconvenience. The embrace of VCBs was associated with significantly higher odds of HPV vaccine hesitancy/resistance. The current study showed the detrimental impact of endorsing vaccine conspiracy beliefs manifested in lower intention to get HPV vaccination among female university students in Kuwait. This should be considered in vaccine promotion efforts aiming to reduce the burden of HPV cancers.

Citing Articles

Gender-neutral vs. gender-specific strategies in school-based HPV vaccination programs: a systematic review and meta-analysis.

Chandeying N, Khantee P, Puetpaiboon S, Thongseiratch T Front Public Health. 2025; 13:1460511.

PMID: 40041177 PMC: 11876415. DOI: 10.3389/fpubh.2025.1460511.


Perceived benefits, information, vaccination history, and conspiracy beliefs as significant determinants of RSV vaccine acceptance among Arab seniors.

Sallam M, Al-Mahzoum K, Yousef Z, Alfouzan J, Alharbi M, Alsubaiei M Ther Adv Vaccines Immunother. 2025; 13:25151355251324384.

PMID: 40027198 PMC: 11869265. DOI: 10.1177/25151355251324384.


Awareness and acceptance of human papillomavirus vaccine in the Middle East: A systematic review, meta-analysis, and meta-regression of 159 studies.

Gulle B, Kiran P, Celik S, Varol Z, Siyve N, Emecen A Epidemiol Infect. 2024; 152:e165.

PMID: 39655623 PMC: 11696605. DOI: 10.1017/S0950268824001596.


The Worrying Phenomenon of COVID-19 Vaccine Hesitancy and Its Negative Impact on Pandemic Control Efforts: Common Themes that Emerged in the Middle East and North Africa (MENA) Region.

Mahafzah A, Sallam M, Bakri F, Mubarak M Adv Exp Med Biol. 2024; 1457:299-322.

PMID: 39283434 DOI: 10.1007/978-3-031-61939-7_17.


Attitude towards cholera vaccination and its related factors in Jordan amid the 2022 Middle East outbreak.

Sallam M, Athamneh R, Alkhazaleh R, Alzayadneh L, Jaradat L, Majali T BMC Public Health. 2024; 24(1):2237.

PMID: 39152391 PMC: 11330065. DOI: 10.1186/s12889-024-19768-0.


References
1.
Al-Awadhi R, Chehadeh W, Kapila K . Prevalence of human papillomavirus among women with normal cervical cytology in Kuwait. J Med Virol. 2011; 83(3):453-60. DOI: 10.1002/jmv.21981. View

2.
Abu-Raddad L, Ghanem K, Feizzadeh A, Setayesh H, Calleja J, Riedner G . HIV and other sexually transmitted infection research in the Middle East and North Africa: promising progress?. Sex Transm Infect. 2013; 89 Suppl 3:iii1-4. PMC: 3841741. DOI: 10.1136/sextrans-2013-051373. View

3.
Abi Jaoude J, Khair D, Dagher H, Saad H, Cherfan P, Kaafarani M . Factors associated with Human Papilloma Virus (HPV) vaccine recommendation by physicians in Lebanon, a cross-sectional study. Vaccine. 2018; 36(49):7562-7567. DOI: 10.1016/j.vaccine.2018.10.065. View

4.
Farsi N, Baharoon A, Jiffri A, Marzouki H, Merdad M, Merdad L . Human papillomavirus knowledge and vaccine acceptability among male medical students in Saudi Arabia. Hum Vaccin Immunother. 2021; 17(7):1968-1974. PMC: 8189128. DOI: 10.1080/21645515.2020.1856597. View

5.
Porras C, Tsang S, Herrero R, Guillen D, Darragh T, Stoler M . Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial. Lancet Oncol. 2020; 21(12):1643-1652. PMC: 8724969. DOI: 10.1016/S1470-2045(20)30524-6. View